As we age, the amount and distribution of fat in our bodies changes. Most fat is subcutaneous—meaning it is stored just under the skin. Subcutaneous fat generally does not have detrimental health impacts. In fact, we need ...
Mar 21, 2026
0
39
Obesity has long been the invisible health crisis looming over humanity, with rates climbing globally. There is some positive news now emerging from a multi-decade study spanning several nations. A recent study published ...
A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss?
Apr 17, 2026
0
35
Not every disease announces itself with obvious symptoms. Some develop quietly, going unnoticed until they begin to take a serious toll on health. Metabolic syndrome (MetS) is one of them. Rather than a single disease, it ...
Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a preclinical study by Weill Cornell Medicine investigators. In the study, published in Nature Metabolism, ...
Feb 23, 2026
0
33
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study was carried out ...
Mar 18, 2026
0
31
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial ...
Feb 26, 2026
0
31
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator ...
Jun 8, 2026
0
31
Search the web, and you'll find any number of biohacking techniques for promoting healthy lifespan, from taking cold baths to breathing pressurized oxygen to sleeping under a red light.
May 10, 2026
0
30
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also preserving lean mass, ...
Mar 5, 2026
0
29
